BC-CfE’s research laboratory introduced widespread human pharmacogenetic testing for treatment side effects into routine clinical practice.
The interprofessional HIV/AIDS elective offered through the College of Health Disciplines, University of British Columbia celebrates its 10th anniversary, approximately 250 students have completed the course.
BC-CfE initiates a large cohort study of HIV-positive injection drug users (IDUs) in the Downtown Eastside aimed at addressing barriers to HIV treatment among IDUs.
The first academic Canadian Division of AIDS is established within the Department of Medicine at UBC, headed by Dr. Montaner and based at the BC-CfE.
CLICK FOR NEW HIV-1 RESISTANCE GENOTYPE REPORT NOTICE
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’. For more details and example reports, please click on the button below
